Nathaniel De La Fuente, 62, is a Houston gay man whose life has been shaped by resilience, faith, and a determination to keep ...

This case study presents a 17-year-old male with Klippel-Feil syndrome who developed recurrent transient quadriparesis and ...

Injury Clinic of Arizona says prompt evaluation after workplace injuries may help reduce long-term complications and ...

In today's always connected society, bedtime typically arrives much later than expected. Many individuals routinely forgo ...

(“Vivos” or the “Company”) (NASDAQ: VVOS) , a leading medical device and healthcare services company focused on the treatment of breathing‑related sleep disorders such as obstructive sleep apnea (OSA) ...

Phase 2 data support soluble guanylate cyclase activation using nurandociguat as a potential adjunctive treatment in patients with chronic kidney disease already receiving current standard of care ...

Chronic pain might quietly push people toward developing high blood pressure—and the more widespread the pain, the greater the danger. A massive analysis of over 200,000 adults uncovered strong links ...

OCEANIC-STROKE randomized 12,327 patients within 72 hours of noncardioembolic stroke or high-risk TIA to asundexian 50 mg daily versus placebo atop single or dual antiplatelet therapy. A 26% relative ...

NEW ORLEANS -- Factor XIa (FXIa) inhibition for secondary stroke prevention got a major win in the large OCEANIC-STROKE placebo-controlled trial. Among adults with acute non-cardioembolic ischemic ...

Recurrent stroke burden exceeds 10% within the first year. Dual antiplatelet therapy (DAPT) is recommended for short-term secondary prevention after non-cardioembolic high-risk TIA or ischemic stroke ...

Recurrent stroke risk was highest in patients treated with aspirin monotherapy and lowest in those receiving dual antiplatelet therapy initiated within 72 hours of symptom onset, indicating that both ...